Safety of 5-grass pollen sublingual immunotherapy

被引：0
|
作者：
Monasterolo, G. [1 ]
Renato, R. [2 ]
机构：
[1] SS Annunziata Hosp, Lab Analisi, Savigliano, Italy
[2] NHS, Allergy Unit, Cuneo, Italy
来源：
ALLERGY | 2012年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
575
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review
    Didier, Alain
    Bons, Brigitte
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 777 - 788
  • [2] Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
    Lombardi C.
    Melli V.
    Incorvaia C.
    Ridolo E.
    Clinical and Molecular Allergy, 15 (1)
  • [3] Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America
    Moingeon, Philippe
    Cox, Linda
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (06) : 617 - 623
  • [4] Evaluation of a 5-grass pollen sublingual immunotherapy (SLIT) tablet in a pediatric population at the pollen peak
    Wahn, U.
    Kuna, P.
    Jaeger, S.
    Montagut, A.
    Lheritier-Barrand, M.
    Le Gall, M.
    ALLERGY, 2009, 64 : 465 - 466
  • [5] Comparison of the effect of 5-grass pollen sublingual immunotherapy tablets and drops in children with rhinoconjunctivitis
    Jerzynska, Joanna
    Stelmach, Wlodzimierz
    Majak, Pawel
    Stelmach, Rafal
    Janas, Anna
    Stelmach, Iwona
    ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (01) : 66 - 73
  • [6] Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
    Malling, H-J.
    Montagut, A.
    Melac, M.
    Patriarca, G.
    Panzner, P.
    Seberova, E.
    Didier, A.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (03): : 387 - 393
  • [7] Efficacy and safety of 300IR 5-grass pollen sublingual allergen immunotherapy tablets in adult patients with grass-pollen rhinoconjunctivitis in United States
    Cox, L.
    Casale, T.
    Nayak, A.
    Bernstein, D.
    Mekhaldi, S.
    de Beaumont, O.
    Melac, M.
    Montagut, A.
    Creticos, P.
    ALLERGY, 2011, 66 : 63 - 63
  • [8] Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis
    Didier, Alain
    Malling, Hans-Jorgen
    Worm, Margitta
    Horak, Friedrich
    Jaeger, Siegfried
    Montagut, Armelle
    Andre, Claude
    de Beaumont, Olivier
    Melac, Michel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (06) : 1338 - 1345
  • [9] Real life safety experience with 5-grass pollen sublingual tablet for the treatment of grass pollen-induced allergic rhinoconjunctivitis
    Didier, A.
    Bons, B.
    Zeldin, R. K.
    ALLERGY, 2015, 70 : 114 - 114
  • [10] Safety of the 5-grass pollen sublingual tablet for the treatment of grass pollen-induced allergic rhinoconjunctivitis in subjects with and without asthma
    Zeldin, R. K.
    Cognet-Sice, J.
    Abiteboul, K.
    ALLERGY, 2015, 70 : 259 - 259
12345